Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
L-periaxin interacts with S-periaxin through its PDZ domain.
Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
Early respiratory evaluation should be carried out systematically in patients with multiple sclerosis.
High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
Endocannabinoid signalling and the deteriorating brain.
Fast myelin water fraction estimation using 2D multislice CPMG.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Genomic medicine and risk prediction across the disease spectrum.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Susceptibility genes are enriched in those of the HSV-1/host interactome in psychiatric and neurological disorders.
Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients.
Outcomes after Microvascular Decompression for Patients with Trigeminal Neuralgia and Suspected Multiple Sclerosis.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Pages
« first
‹ previous
…
546
547
548
549
550
551
552
553
554
…
next ›
last »